Brent L. Wood - Concepedia

Author

Brent L. Wood

Also Known As

B L Wood, B Wood, B. L. Wood, B. Wood, BRENT L. WOOD, Brent L Wood, Brent L. Wood, Brent L.Wood, Brent Lee Wood, Brent Wood

617

Publications

45.5K

Citations

H-Index

205

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center Children's Hospital of Philadelphia University of Florida St. Jude Children's Research Hospital

About

Brent L. Wood is an author at University of Washington specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	85	11.3K
2	Health Sciences	21	33	2.8K
3	Engineering	5	5	957
4	Education	1	1	63
5	Natural Sciences	1	1	138

Brent L. Wood

269

Publications

33K

Citations

H-Index

Page 1

	Year	Citations
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients Cameron J. Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Journal of Clinical Investigation	2016	2.1K
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget, New England Journal of Medicine	2017	2K
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 <sup>+</sup> and CD4 <sup>+</sup> CD19-specific chimeric antigen receptor–modified T cells Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger, Science Translational Medicine ImmunologyPathologyCd4 T Cell ResponsesT CellsImmunotherapy	2016	989
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia Yu Liu, John Easton, Ying Shao, Nature Genetics Hematological MalignancyGenomic LandscapeMixed-phenotype Acute LeukemiaGeneticsMalignant Blood Disorder	2017	910
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies Colin C. Pritchard, Evan M. Kroh, Brent L. Wood, Cancer Prevention Research	2011	866
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist W. Conrad Liles, Hal E. Broxmeyer, Elin Rodger, Blood	2003	715
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells Brian G. Till, Michael C. Jensen, Jinjuan Wang, Blood	2008	714
The genomic landscape of hypodiploid acute lymphoblastic leukemia Linda Holmfeldt, Lei Wei, Ernesto Díaz-Flores, Nature Genetics Hematological MalignancyGenomic LandscapeMixed-phenotype Acute LeukemiaGeneticsHematology	2013	696
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele, Blood Mixed-phenotype Acute LeukemiaPathologyMeasurable Residual DiseaseMyeloid NeoplasiaHematological Malignancy	2021	666
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib Cameron J. Turtle, Kevin A. Hay, Laïla‐Aïcha Hanafi, Journal of Clinical Oncology	2017	649

Page 1